MS is known to be linked to Immune system dysfunction and the process is beginning to be understood through extensive research of the function and pathways for Vit D to be effective. The findings that pathogens/infections are involved in the early stages of MS development, before symptoms commence and before technology can 'measure' the outcomes of the MS 'cascade', is helping to link all the dots.
The findings such as CCSVI and Vascular dysfunctions which create the breach of the blood brain barrier (BBB) and allow the blood to carry infections across into the central nervous system (Brain) where they are not meant to be and neither is the immune system from outside of the Central Nervous System (CNS). The CNS has it's own separate immune system within the Cerebo Spinal Fluid (CSF).
When the bodies immune system cells such as CD4 and T regs, enter the CNS through the BBB breaches, they are uncontrolled by the bodies immune system when inside the CNS and do damage to the Nervous System/Myelin because the bodies immune system cells are no longer directed by Vit D receptors as it would because the infection has caused problems with the conversion process of Vit D and/or has immobilised the Vit D receptors inside the CNS.
Re-setting the rogue bodies immune cells with calcitriol and Vit D treatments shows HUGE promise for PwMS and trials need to be established some how!!
Abstract
Multiple sclerosis (MS) is an incurable inflammatory demyelinating disease. We investigated one calcitriol dose plus vitamin D3 (calcitriol/+D) as a demyelinating disease treatment in experimental autoimmune encephalomyelitis (EAE). Evidence that calcitriol-vitamin D receptor pathway deficits may promote MS, and data showing calcitriol enhancement of autoimmune T cell apoptosis provided the rationale. Whereas vitamin D3 alone was ineffective, calcitriol/+D transiently increased central nervous system (CNS) Helios(+)FoxP3(+) T cells and sustainably decreased CNS T cells, pathology, and neurological deficits in mice with EAE. Calcitriol/+D, which was more effective than methylprednisolone, has potential for reversing inflammatory demyelinating disease safely and cost-effectively.
http://www.ncbi.nlm.nih.gov/pubmed/23968560
Full paper @;
http://fairyofdisenchantment.files.word ... _15_13.pdf
Regards,
Nigel
